Article Information
History
- April 29, 2022.
Article Versions
- Version 1 (February 19, 2021 - 10:15).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Dongyu Kang, M.D.a,#,
- Fengyu Zhang, PhD. MSb,c,#,
- Ye Yang, M.D.a,
- Chenchen Liu, M.D.a,
- Jingmei Xiao, M.D.a,
- Yujun Long, M.D.a,
- Jing Huang, M.D. PhD.a,
- Xingjie Peng, M.D.a,
- Weiyan Wang, M.D.a,
- Xiaoyi Wang, M.D.a,
- John M. Davis, M.D.d,
- Jingping Zhao, M.D. PhD.a and
- Renrong Wu, M.D. PhD.a,e,*
- aNational Clinical Research Center for Metabolic Diseases, and Department of Psychiatry, the Second Xiangya Hospital of Central South University, Changsha 410011, Hunan, China
- bBeijing Huilongguan Hospital and Peking University Huilongguan Clinical Medical School, Beijing, China
- cGlobal Clinical and Translational Research Institute, Bethesda, MD, USA
- dPsychiatric Institute, University of Illinois, Chicago, IL, USA
- eShanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China
- ↵*Corresponding author and E-mail address:
Renrong Wu, MD PhD, Mental Health Institute of the Second Xiangya Hospital, Central South University, Changsha, Hunan, China, E-mail: wurenrong{at}csu.edu.cn, Tel: +86 15874179855;Fax: +86 73185295214
↵# Authors contributed equally to this work.
Posted April 29, 2022.
Probiotic supplements reduce antipsychotic-induced metabolic disturbances in drug-naïve first-episode schizophrenia
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos